Literature DB >> 21793310

Lindane-induced biochemical perturbations in rat serum and attenuation by omega-3 and Nigella sativa seed oil.

Ahmed M Attia1, Sabah G El-Banna, Farid R Nomeir, Mohammed I Abd El-Basser.   

Abstract

Lindane (gamma-hexachlorocyclohexane, gamma-HCH), a highly persistent organochlorine insecticide is neurotoxic at acute doses and has been reported to induce oxidative stress in cells and tissues. In this study, we investigated the antioxidant property of Nigella sativa seed oil (N.O) and omega-3 polyunsaturated fatty acids (omega3) against gamma-HCH-induced oxidative hepatic and renal damage in male rats serum. Rats were orally given sublethal dose of gamma-HCH (12 mg/kg, 24 h prior to decapitation), while N.O (0.3 ml/kg) and omega3 (20 mg/kg) were given every 48 h for 20 days single or together, or also combined with gamma-HCH. gamma-HCH caused a significant increase in the levels of serum total lipids, cholesterol, and triglycerides by 49, 61 and 30% respectively, while HDL-cholesterol decreased by 45% compared to control group. Pretreatment with omega3 and N.O prior gamma-HCH administration re-established the altered biochemical features and alleviated the harmful effects of gamma-HCH on lipid profile. The concentration of serum total protein and albumin was significantly decreased by 35 and 45% respectively in rats treated with gamma-HCH compared to control. gamma-HCH also caused hepatic and renal damage, as observed from the elevated serum levels of urea, creatinine, total bilirubin and uric acid contents and aminotransferases (AST and ALT), phosphatases (ACP and ALP) and lactate dehydrogenase (LDH) activities. Co-administration of omega3 and N.O reversed the hazardous effects induced by gamma-HCH on the liver and kidney and also protected acetylcholinesterase from the inhibitory action of gamma-HCH as well as suppressed the lipid peroxidation. Thus, the results show that omega3 and N.O might prevent oxidative stress and attenuate the changes in the biochemical parameters induced by gamma-HCH in male rats.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21793310

Source DB:  PubMed          Journal:  Indian J Biochem Biophys        ISSN: 0301-1208            Impact factor:   1.918


  7 in total

Review 1.  Nuclear receptors and nonalcoholic fatty liver disease.

Authors:  Matthew C Cave; Heather B Clair; Josiah E Hardesty; K Cameron Falkner; Wenke Feng; Barbara J Clark; Jennifer Sidey; Hongxue Shi; Bashar A Aqel; Craig J McClain; Russell A Prough
Journal:  Biochim Biophys Acta       Date:  2016-03-04

Review 2.  Metabolism disrupting chemicals and metabolic disorders.

Authors:  Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal
Journal:  Reprod Toxicol       Date:  2016-10-17       Impact factor: 3.143

3.  Attenuation of Lead-Induced Neurotoxicity by Omega-3 Fatty Acid in Rats.

Authors:  Pramod Kumar Singh; Manish Kumar Singh; Rajesh Singh Yadav; Rakesh Kumar Dixit; Anju Mehrotra; Rajendra Nath
Journal:  Ann Neurosci       Date:  2017-10-18

4.  Protective role of omega-3 polyunsaturated fatty acid against lead acetate-induced toxicity in liver and kidney of female rats.

Authors:  Heba M Abdou; Mohamed A Hassan
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

5.  THE SERUM PROTEIN FRACTIONS IN THYMOQUINONE TREATED RATS.

Authors:  Güllü A; Dede S
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-09-29

Review 6.  Endocrine Disruptors Leading to Obesity and Related Diseases.

Authors:  Demetrios Petrakis; Loukia Vassilopoulou; Charalampos Mamoulakis; Christos Psycharakis; Aliki Anifantaki; Stavros Sifakis; Anca Oana Docea; John Tsiaoussis; Antonios Makrigiannakis; Aristides M Tsatsakis
Journal:  Int J Environ Res Public Health       Date:  2017-10-24       Impact factor: 3.390

Review 7.  The Liver in Children With Metabolic Syndrome.

Authors:  Ebe D'Adamo; Valeria Castorani; Valerio Nobili
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-02       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.